Metraipolis › archive › dc_70ff53ba90fa

Divergent effects of semaglutide and CRV431 Co-therapy on liver fibrosis and HCC in MASLD mouse model — Europe PMC PMID:42758714

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42758714
DOI
10.1371/journal.pone.0358225
License (as archived)
solo-consultazione
Archived
2026-10-08T06:15:51.916Z
SHA-256 of the archived text
675f455231044fc3ae3d0e04288869e7e6c577c4295eaa1933236a13155e3f2c
Stable URL of this page
https://metraipolis.com/documento/dc_70ff53ba90fa

How to cite

Divergent effects of semaglutide and CRV431 Co-therapy on liver fibrosis and HCC in MASLD mouse model — Europe PMC PMID:42758714 — Europe PMC (en), https://europepmc.org/article/MED/42758714 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_70ff53ba90fa (Metraipolis archive dc_70ff53ba90fa, sha256 675f455231044fc3ae3d0e04288869e7e6c577c4295eaa1933236a13155e3f2c)
BibTeX
@misc{dc70ff53ba90fa,
  title = {Divergent effects of semaglutide and CRV431 Co-therapy on liver fibrosis and HCC in MASLD mouse model — Europe PMC PMID:42758714},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42758714},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_70ff53ba90fa; sha256 675f455231044fc3ae3d0e04288869e7e6c577c4295eaa1933236a13155e3f2c},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42758714. Agents can read the archived copy with the MCP tool read_document.